Although these differences did not reach statistical significance, they may reflect variability in individual disease progression and emphasize the potential role of VEP amplitude in detecting subclinical progression, consistent with previous observations of differential treatment effects in MS pathophysiology and disease activity patterns ( 28 ). 4.4.
← all excerpts
From demyelination to neurodegeneration in multiple sclerosis: reassessing the role of visual evoked potential P100-N145 amplitudes: a missing piece of the puzzle?
1
—
—